VIR - Vir Biotechnology, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 10.39

Open

$ 10.34

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 10.10 - $ 10.56

52 Week Range

$ 7.61 - $ 27.48

Volume

1,690,966

Average Volume

Market Cap

1.41B

Beta (5Y Monthly)

$ -0.81

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-03-2024	03-31-2024	10-Q
2	02-26-2024	12-31-2023	10-K
3	11-03-2023	09-30-2023	10-Q
4	08-04-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-11-2020	06-30-2020	10-Q
17	05-12-2020	03-31-2020	10-Q
18	03-26-2020	12-31-2019	10-K
19	11-19-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Neutral on Vir Biotech...
05/03/2024 19:17:37

JP Morgan analyst Eric Joseph maintains Vir Biotechnology (NASDAQ:VIR) with a Neutral and raises the price target from $10 t...

Needham Reiterates Buy on Vir Biotechnolog...
05/03/2024 19:15:23

Needham analyst Joseph Stringer reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $15 price target.

Vir Biotechnology Reiterates FY24 GAAP Com...
05/02/2024 20:22:03

Vir Biotechnology Q1 2024 GAAP EPS $(0.48)...
05/02/2024 20:10:14

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(1....

On April 15, 2024, Sung Lee, Executive Vic...
04/18/2024 12:49:08

On April 15, 2024, Sung Lee, Executive Vice President and Chief Financial Officer of Vir Biotechnology, Inc. (the "Company&...

Assessing Vir Biotechnology: Insights From...
03/15/2024 14:00:25

HC Wainwright & Co. Reiterates Buy on Vir ...
03/15/2024 13:26:48

HC Wainwright & Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $110 pri...

Vir Biotechnology Completes Enrollment Of ...
03/05/2024 13:06:13

– Over 60 participants dosed in two additional cohorts; initial data expected in the second quarter –– Approximately 50% of par...

why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Why MercadoLibre Shares Are Trading Lower ...
02/23/2024 19:07:11

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

carvana-posts-q4-results-joins-legalzoomcom-comfort-systems-and-other-big-stocks-moving-higher-on-friday

Carvana Posts Q4 Results, Joins LegalZoom....
02/23/2024 16:58:59

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

Vir Biotechnology Q4 2023 GAAP EPS $(0.86)...
02/22/2024 21:36:59

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1....

Recap: Vir Biotechnology Q4 Earnings
02/22/2024 21:10:10

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Earnings Outlook For Vir Biotechnology
02/21/2024 14:02:03

HC Wainwright & Co. Maintains Buy on Vir B...
02/14/2024 11:42:05

HC Wainwright & Co. analyst Patrick Trucchio maintains Vir Biotechnology (NASDAQ:VIR) with a Buy and raises the price ta...

JP Morgan Downgrades Vir Biotechnology: He...
01/29/2024 17:00:35

JP Morgan Downgrades Vir Biotechnology to ...
01/29/2024 11:06:41

JP Morgan analyst Eric Joseph downgrades Vir Biotechnology (NASDAQ:VIR) from Overweight to Neutral and lowers the price targ...

HC Wainwright & Co. Maintains Buy Rating f...
01/23/2024 17:00:10

covax-global-initiative-for-covid-19-vaccines-comes-to-an-end-amid-shift-to-regular-programs

COVAX Global Initiative For COVID-19 Vacci...
12/20/2023 15:54:34

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December ...

Vir Biotechnology Reports $1.7B In Cash, C...
12/13/2023 21:11:21